Dynamic in Vivo Binding of STAT5 to Growth Hormone-regulated Genes in Intact Rat Liver. Sex-specific Binding at Low- but Not High-affinity STAT5 Sites
Overview
Molecular Biology
Affiliations
Phylogenetic footprinting was used to predict functional transcription factor binding sites (TFBS) for signal transducer and activator of transcription (STAT) 5, a GH-activated transcription factor, in the GH-responsive genes IGF-I, SOCS2, and HNF6. Each gene, including upstream (100 kb) and downstream regions (25 kb), was aligned across four species and searched for conserved STAT5-binding sites using TFBS matrices. Predicted sites were classified as paired or single and whether or not they matched the STAT5 consensus sequence TTCN(3)GAA. Fifty-seven of the predicted genomic regions were assayed by chromatin immunoprecipitation from male rat liver with high STAT5 activity. STAT5 binding was enriched (up to 24-fold) at eight genomic regions of IGF-I, including three novel regions in the second intron, and at four regions of SOCS2, including three novel upstream sites. STAT5 binding to HNF6 was modestly enriched (up to 3-fold) at one consensus site and two novel, nonconsensus sites. Overall, 14 of 17 identified sites were paired STAT5 sites. STAT5 binding to these sites was dynamic in male rat liver, cycling on and off in response to each plasma GH pulse. Moreover, sex-specific STAT5 binding was apparent; in female rat liver, where nuclear STAT5 activity is generally low, STAT5 binding to IGF-I and SOCS2 was limited to high-affinity sites. Analysis of the verified STAT5 binding sites indicated that STAT5 TFBS matrix 459 in combination with a STAT5 consensus sequence was the best predictor of STAT5 binding to these three genes. Using these criteria, multiple novel STAT5 binding sites were identified and then verified in several other GH-inducible genes, including MUP genes, where male-specific gene expression was associated with male-specific STAT5 binding to multiple low-affinity STAT5 sites.
Chhabra Y, Bielefeldt-Ohmann H, Brooks T, Brooks A, Waters M Endocrinology. 2024; 165(11).
PMID: 39378329 PMC: 11500606. DOI: 10.1210/endocr/bqae136.
Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.
Strous G, Almeida A, Putters J, Schantl J, Sedek M, Slotman J Front Endocrinol (Lausanne). 2020; 11:597573.
PMID: 33312162 PMC: 7708378. DOI: 10.3389/fendo.2020.597573.
Della Torre S Front Endocrinol (Lausanne). 2020; 11:572490.
PMID: 33071979 PMC: 7531579. DOI: 10.3389/fendo.2020.572490.
Regulation of gene expression by growth hormone.
Rotwein P Mol Cell Endocrinol. 2020; 507:110788.
PMID: 32151566 PMC: 7138728. DOI: 10.1016/j.mce.2020.110788.
Diversification of the insulin-like growth factor 1 gene in mammals.
Rotwein P PLoS One. 2017; 12(12):e0189642.
PMID: 29240807 PMC: 5730178. DOI: 10.1371/journal.pone.0189642.